PressApril 14, 2023 Sunstone Therapies Announces Publication of Positive Data on Use of Psilocybin Therapy for Patients with Cancer and Major Depression Disorder, in JAMA Oncology
PressApril 14, 2023 atai Life Sciences Announces First Subject Dosed in the Phase 1 IV-to-Subcutaneous Bridging Study of PCN-101 (R-Ketamine)
PressApril 11, 2023 Numinus Launches new Clinic Licensing Platform, the Numinus Network, to Accelerate Expansion
PressApril 11, 2023 Mydecine Innovations Group Files Prospectus Supplement and Announces Closing Under Share Subscription Agreement
PressApril 11, 2023 COMPASS Pathways to participate in upcoming 22nd Annual Needham Virtual Healthcare Conference
PressApril 11, 2023 Bright Minds Biosciences to Present at the 20th International Meeting of the International Society for Serotonin Research
PressApril 7, 2023 MAPS PBC Announces Positive Topline Results from Long-Term Observational Follow-Up Study on MDMA-Assisted Therapy for Treatment of PTSD
